Longitudinal assessment of fatigue and health-related quality of life in adults with immune thrombocytopenia in China

Author:

Zhang Wenhui1,Xie Shitong2,Fu Rongfeng1,Chen Yunfei1,Liu Wei1,Sun Ting1,Ju Mankai1,Li Huiyuan1,Xue Feng1,Zhang Lei1,Liu Xiaofan1,Yang Renchi1

Affiliation:

1. National Clinical Research Center for Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College

2. Tianjin University

Abstract

Abstract Background Currently, there are few studies focusing on fatigue and health-related quality of life (HRQoL) longitudinally among immune thrombocytopenia (ITP) adults, especially in China. We aimed to evaluate changes in fatigue and HRQoL and identify the associated factors from admission to three months after discharge in Chinese adult ITP patients. Methods Patients’ characteristics, and the self-reported answers of the Functional Assessment of Chronic Illness Therapy (FACIT-F) and the ITP-specific Patient Assessment Questionnaire (ITP-PAQ) at admission (T0), at discharge (T1), and three months after discharge (T2) were collected. Linear mixed effects models were used to examine overall changes over time and associated factors in FACIT-F and ITP-PAQ scores at T0, T1, T2. Results The data of 175 ITP adults were included. The mean score of FACIT-F at T0 was 37.2 and increased to 39.0 at T1, while then tended to decrease to the level of baseline at T2 (34.7). Patients who were single, retired, had persistent ITP, splenomegaly had more severe fatigue, whereas those who had not received any prior treatment and had a bleeding score of 0 at admission had milder fatigue. The mean score of ITP-PAQ was 57.7 at T0, then gradually increased to 60.3 at T1 and 62.8 at T2. Patients with persistent ITP and those who have never received treatment for ITP have better HRQoL. Conclusion Adult ITP patients in China have non-negligible impairment in fatigue and HRQoL. Patients' fatigue improved at discharge but worsened at three months after discharge, while HRQoL gradually improved over time.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3